市場調査レポート概要
グローバルの抗体薬物複合体受託製造市場について調査・分析を行った市場調査レポート。抗体薬物複合体受託製造の市場規模、市場成長率、成長ドライバーや事業機会の分析に加えて、この市場における主要企業・プレイヤーや、シェアあるいは競争環境についての考察を、定量的データを交えて提供。 ※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
Description
Table of Contents
Figures
List of Tables Table 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 Table 2. Major Companies of IgG1 Table 3. Major Companies of IgG4 Table 4. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 Table 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (US$ Million): 2023 VS 2030 Table 6. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Region (2019-2024) & (US$ Million) Table 7. Global Antibody Drug Conjugates Contract Manufacturing Revenue Forecast by Region (2025-2030) & (US$ Million) Table 8. Antibody Drug Conjugates Contract Manufacturing Revenue by Company (2019-2024) & (US$ Million) Table 9. Antibody Drug Conjugates Contract Manufacturing Revenue Share by Company (2019-2024) Table 10. Ranking of Global Top Antibody Drug Conjugates Contract Manufacturing Players by Revenue (US$ Million) in 2023 Table 11. Global Antibody Drug Conjugates Contract Manufacturing Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024) Table 12. Global Antibody Drug Conjugates Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2023) Table 13. Global Antibody Drug Conjugates Contract Manufacturing Companies Headquarters Table 14. Global Antibody Drug Conjugates Contract Manufacturing Companies Product & Service Table 15. Date of International Companies Enter into Antibody Drug Conjugates Contract Manufacturing Market Table 16. Global Antibody Drug Conjugates Contract Manufacturing Mergers & Acquisitions, Expansion Plans Table 17. Lonza Group Company Information Table 18. Lonza Group Description and Business Overview Table 19. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product Table 20. Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 21. Lonza Group Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 22. Lonza Group Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 23. Lonza Group Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 24. Lonza Group Recent Development Table 25. Merck KGaA Company Information Table 26. Merck KGaA Description and Business Overview Table 27. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product Table 28. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 29. Merck KGaA Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 30. Merck KGaA Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 31. Merck KGaA Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 32. Merck KGaA Recent Development Table 33. Recipharm Company Information Table 34. Recipharm Description and Business Overview Table 35. Recipharm Antibody Drug Conjugates Contract Manufacturing Product Table 36. Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 37. Recipharm Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 38. Recipharm Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 39. Recipharm Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 40. Recipharm Recent Development Table 41. Thermo Fisher Scientific Company Information Table 42. Thermo Fisher Scientific Description and Business Overview Table 43. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product Table 44. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 45. Thermo Fisher Scientific Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 46. Thermo Fisher Scientific Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 47. Thermo Fisher Scientific Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 48. Thermo Fisher Scientific Recent Development Table 49. Abbvie Company Information Table 50. Abbvie Description and Business Overview Table 51. Abbvie Antibody Drug Conjugates Contract Manufacturing Product Table 52. Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 53. Abbvie Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 54. Abbvie Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 55. Abbvie Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 56. Abbvie Recent Development Table 57. Piramal Pharma Solutions Company Information Table 58. Piramal Pharma Solutions Description and Business Overview Table 59. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product Table 60. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 61. Piramal Pharma Solutions Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 62. Piramal Pharma Solutions Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 63. Piramal Pharma Solutions Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 64. Piramal Pharma Solutions Recent Development Table 65. Catalent Company Information Table 66. Catalent Description and Business Overview Table 67. Catalent Antibody Drug Conjugates Contract Manufacturing Product Table 68. Catalent Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 69. Catalent Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 70. Catalent Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 71. Catalent Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 72. Catalent Recent Development Table 73. Sterling Pharma Solutions Company Information Table 74. Sterling Pharma Solutions Description and Business Overview Table 75. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product Table 76. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 77. Sterling Pharma Solutions Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 78. Sterling Pharma Solutions Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 79. Sterling Pharma Solutions Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 80. Sterling Pharma Solutions Recent Development Table 81. Curia Company Information Table 82. Curia Description and Business Overview Table 83. Curia Antibody Drug Conjugates Contract Manufacturing Product Table 84. Curia Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 85. Curia Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 86. Curia Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 87. Curia Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 88. Curia Recent Development Table 89. Novasep Company Information Table 90. Novasep Description and Business Overview Table 91. Novasep Antibody Drug Conjugates Contract Manufacturing Product Table 92. Novasep Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 93. Novasep Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 94. Novasep Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 95. Novasep Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 96. Novasep Recent Development Table 97. Ajinomoto Bio-Pharma Services Company Information Table 98. Ajinomoto Bio-Pharma Services Description and Business Overview Table 99. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product Table 100. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 101. Ajinomoto Bio-Pharma Services Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 102. Ajinomoto Bio-Pharma Services Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 103. Ajinomoto Bio-Pharma Services Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 104. Ajinomoto Bio-Pharma Services Recent Development Table 105. BSP Pharmaceuticals Company Information Table 106. BSP Pharmaceuticals Description and Business Overview Table 107. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product Table 108. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 109. BSP Pharmaceuticals Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 110. BSP Pharmaceuticals Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 111. BSP Pharmaceuticals Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 112. BSP Pharmaceuticals Recent Development Table 113. Cerbios-Pharma Company Information Table 114. Cerbios-Pharma Description and Business Overview Table 115. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product Table 116. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 117. Cerbios-Pharma Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 118. Cerbios-Pharma Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 119. Cerbios-Pharma Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 120. Cerbios-Pharma Recent Development Table 121. Goodwin Biotechnology Company Information Table 122. Goodwin Biotechnology Description and Business Overview Table 123. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product Table 124. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 125. Goodwin Biotechnology Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Product in 2023 Table 126. Goodwin Biotechnology Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Application in 2023 Table 127. Goodwin Biotechnology Revenue Proportion of Antibody Drug Conjugates Contract Manufacturing by Geographic Area in 2023 Table 128. Goodwin Biotechnology Recent Development Table 129. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 130. Global Antibody Drug Conjugates Contract Manufacturing Revenue Forecast by Type (2025-2030) & (US$ Million) Table 131. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 132. Global Antibody Drug Conjugates Contract Manufacturing Revenue Forecast by Application (2025-2030) & (US$ Million) Table 133. North America Antibody Drug Conjugates Contract Manufacturing Revenue by Country (2019-2024) & (US$ Million) Table 134. North America Antibody Drug Conjugates Contract Manufacturing Revenue by Country (2025-2030) & (US$ Million) Table 135. North America Antibody Drug Conjugates Contract Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 136. North America Antibody Drug Conjugates Contract Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 137. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Revenue by Region (2019-2030) & (US$ Million) Table 138. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Revenue by Region (2025-2030) & (US$ Million) Table 139. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 140. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 141. Europe Antibody Drug Conjugates Contract Manufacturing Revenue by Country (2019-2024) & (US$ Million) Table 142. Europe Antibody Drug Conjugates Contract Manufacturing Revenue by Country (2025-2030) & (US$ Million) Table 143. Europe Antibody Drug Conjugates Contract Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 144. Europe Antibody Drug Conjugates Contract Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 145. Latin America Antibody Drug Conjugates Contract Manufacturing Revenue by Country (2019-2024) & (US$ Million) Table 146. Latin America Antibody Drug Conjugates Contract Manufacturing Revenue by Country (2025-2030) & (US$ Million) Table 147. Latin America Antibody Drug Conjugates Contract Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 148. Latin America Antibody Drug Conjugates Contract Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 149. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Revenue by Country (2019-2024) & (US$ Million) Table 150. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Revenue by Country (2025-2030) & (US$ Million) Table 151. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 152. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 153. Antibody Drug Conjugates Contract Manufacturing Key Raw Materials, Industry Status and Trend Table 154. Antibody Drug Conjugates Contract Manufacturing Key Raw Materials and Upstream Suppliers Table 155. Antibody Drug Conjugates Contract Manufacturing Clients Status and Trend Table 156. Antibody Drug Conjugates Contract Manufacturing Typical Clients Table 157. Antibody Drug Conjugates Contract Manufacturing Distributors Table 158. Antibody Drug Conjugates Contract Manufacturing Market Trends Table 159. Antibody Drug Conjugates Contract Manufacturing Market Drivers Table 160. Antibody Drug Conjugates Contract Manufacturing Market Challenges Table 161. Antibody Drug Conjugates Contract Manufacturing Market Restraints Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Antibody Drug Conjugates Contract Manufacturing Product Picture Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type in 2023 & 2030 Figure 3. IgG1 Product Picture Figure 4. IgG4 Product Picture Figure 5. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application in 2023 & 2030 Figure 6. Solid Tumors Figure 7. Hematological Malignancies Figure 8. Antibody Drug Conjugates Contract Manufacturing Report Years Considered Figure 9. Global Antibody Drug Conjugates Contract Manufacturing Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 10. Global Antibody Drug Conjugates Contract Manufacturing Market Size 2019-2030 (US$ Million) Figure 11. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Region: 2023 Versus 2030 Figure 12. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Region (2019-2030) Figure 13. Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023 Figure 14. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share Forecast by Type (2019-2030) Figure 15. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share Forecast by Application (2019-2030) Figure 16. North America Antibody Drug Conjugates Contract Manufacturing Revenue 2019-2030 (US$ Million) Figure 17. North America Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2019-2024) Figure 18. North America Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2019-2024) Figure 19. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Revenue 2019-2030 (US$ Million) Figure 20. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Region (2019-2030) Figure 21. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2019-2024) Figure 22. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2019-2024) Figure 23. Europe Antibody Drug Conjugates Contract Manufacturing Revenue Growth Rate 2019-2030 (US$ Million) Figure 24. Europe Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Country (2019-2030) Figure 25. Europe Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2019-2024) Figure 26. Europe Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2019-2024) Figure 27. Latin America Antibody Drug Conjugates Contract Manufacturing Revenue Growth Rate 2019-2030 (US$ Million) Figure 28. Latin America Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Country (2019-2024) Figure 29. Latin America Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2019-2024) Figure 30. Latin America Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2019-2024) Figure 31. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Revenue Growth Rate 2019-2030 (US$ Million) Figure 32. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Country (2019-2030) Figure 33. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2019-2024) Figure 34. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2019-2024) Figure 35. Antibody Drug Conjugates Contract Manufacturing Supply Chain (Upstream and Downstream Market) Figure 36. Global Production Market Share of Antibody Drug Conjugates Contract Manufacturing Raw Materials by Region in 2023 Figure 37. Antibody Drug Conjugates Contract Manufacturing Distribution Channels Figure 38. Global Antibody Drug Conjugates Contract Manufacturing Percentage 2019-2030: Indirect Sales VS Direct Sales Figure 39. Global Antibody Drug Conjugates Contract Manufacturing Percentage 2019-2030: Online Sales VS Offline Sales Figure 40. Bottom-up and Top-down Approaches for This Report Figure 41. Data Triangulation Figure 42. Key Executives Interviewed Figure 43. Global Antibody Drug Conjugates Contract Manufacturing Percentage 2019-2030: Online Sales VS Offline Sales Figure 44. Bottom-up and Top-down Approaches for This Report Figure 45. Data Triangulation Figure 46. Key Executives Interviewed
